Revision to AT&T 10-Year Targets

Please note that the 10-year targets for AT&T has been updated and can been found here.

Chart of the Day: Determine Inc.

According to Yahoo!Finance, “Determine, Inc. provides software-as-a-service source-to-pay and enterprise contract lifecycle management (ECLM) solutions. The company offers Determine Cloud Platform, an open technology infrastructure for application in strategic sourcing, contract management, e-procurement, invoice management, financial management, supplier management, business applications, ECLM, and analytics.”

image

The Study of Failure

"When you retire, you better return TO something.  I don't care if it's golf, biking, traveling, or collecting something.  But just to retire and vegetate--big mistake. You can die of boredom or a feeling of uselessness.  It's the 'use it or lose it' syndrome (Russell, Richard. Dow Theory Letters. September 25, 1996. page 5.)."

AT&T 10-Year Targets

Below are the valuation targets for AT&T (T) for the next 10 years. Continue reading

Chubb Limited 10-Year Targets

Below are the valuation targets for Chubb Limited (CB) for the next 10 years. Continue reading

Chart of the Day: DropCar Inc.

According to Yahoo!Finance, “DropCar, Inc. provides app-based automotive logistics and mobility services for consumers and the automotive industry. The company offers Vehicle Support Platform, a cloud-based platform and mobile app that help consumers and automotive-related companies in reducing the cost, hassles, and inefficiencies of owning a car or fleet of cars in urban centers.”

image

The Study of Failure

"...I bought Berkshire Hathaway at $250 in the late-1960s. I sold it a few years later for $550, proudly doubling my money. Then I watched it go to a high of $9,950.  It was a classic case of what I call losing while winning (Russell, Richard. Dow Theory Letters. September 2, 1992. page 5.)."

Berkshire Hathaway (BRK-A) is at $328,350.00 as of November 16, 2018.

Facebook Downside Targets

Below are the downside targets for Facebook (FB) based on the decline from the July 25, 2018 peak at $217.50. Continue reading

Apple Inc. Downside Targets

On April 14, 2012, we provided the following downside targets for Apple Inc. (AAPL):

pre-split price post-split price
$424.15 $60.59
$297.43 $42.49
$212.08 $30.30
$117.05 $16.72

Along with the downside targets we included a charting of the expected levels, as seen below on a split adjusted basis:

image

On July 17, 2013, we said the following of of Apple:

“Currently, Apple is demonstrating a basing pattern that if successful, could result in a breakout to the upside.  At the current levels, we wouldn’t be opposed to buying some shares of Apple with the expectation that the stock could decline an additional –25% to –35%.”

Since July 17, 2013, Apple’s price has seen the following breakout to the upside:

image

Below are the Speed Resistance Lines based on the work of Edson Gould as of November 19, 2018.  As has been the case in the past, we can only be confident of the conservative downside target being achieved. Continue reading

Chart of the Day: MoSys Inc.

According to Yahoo!Finance, “MoSys, Inc., a semiconductor company, develops and sells integrated circuits (ICs) for the high-speed cloud networking, communications, security appliance, video, monitor and test, data center, and computing markets.”

image

The Study of Failure

"Successful investing is a lifelong process. Some years are better than others, and it is a mistake to denominate financial progress into 12-month periods. A lifetime of successful investing requires a lifetime to accomplish (Russell, Richard. Dow Theory Letters. Geraldine Weiss on Investing. January 22, 1992. page 3.)."

Chart of the Day: Revolution Lighting Technologies

According to Yahoo!Finance, “Revolution Lighting Technologies, Inc. designs, manufactures, markets, and sells light-emitting diode (LED) lighting solutions focusing on the industrial, commercial, and government markets in the United States, Canada, and internationally.”

image

The Study of Failure

"Everybody is wrong on the market at certain times, and that's par for the course.  It's OK to be wrong, but the unforgivable act is to STAY wrong (Russell, Richard. Dow Theory Letters. January 8, 1992. page 5.)."

U.S. Dividend Watch List: November 16, 2018

The S&P 500 was down 1.3% for the week. One positive sign was the fact that the market didn't close below 2,700 level. From the technical perspective, a 2,800 level is a crucial one for the upward bias to continue. If the market can break above that level, the all-time high would likely be the next stop. Below are companies that are on our watch list for this week. Continue reading

Travelers Companies 10-Year Targets

Below are the valuation targets for Travelers Companies (TRV) for the next 10 years. Continue reading

T. Rowe Price 10-year Target

Below are the valuation targets for T. Rowe Price (TROW) for the next 10 years. Continue reading

ExxonMobil 10-Year Targets

Below are the valuation targets for ExxonMobil (XOM) for the next 10 years. Continue reading

People’s United Financial Inc. 10-Year Targets

Below are the valuation targets for People’s United Financial Inc. (PBCT) for the next 10 years. Continue reading

Chart of the Day: Rennova Health Inc.

According to Yahoo!Finance, “Rennova Health, Inc., together with its subsidiaries, provides a suite of healthcare related products and services to healthcare providers in the United States. The company operates in three segments: Laboratory Services, Supportive Software Solutions, and Decision Support and Informatics Operations. It provides toxicology, clinical pharmacogenetics, and esoteric testing services. The company also offers Advantage, a HIPAA compliant software; Clinlab, a Windows-based Web-enabled laboratory information management system; and Medical Mime, a suite of solutions, which include an optimized Electronic health records (EHR) for substance abuse and behavioral health providers, a dictation-based ambulatory EHR for physician practices, and advanced transcription services. In addition, it develops and markets interpretation and decision support solutions that enhance cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients.”

image

Rennova Health traded from November 21, 2008 to January 2018 at –99% below the price of the peak established in 1995.

The Study of Failure

"The marvelous thing about the stock market is this--it's always there. Make a mistake, and you can call your broker and blow out that mistake in 30 seconds (try doing that in your own business).  Miss a move, and it's just a matter of time before a second and a third and a fourth opportunity arrives.  Sell too soon, and you can buy back in a few minutes. (Russell, Richard. Dow Theory Letters. May 15, 1991. page 3.)"